Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re Cymer

Rev over 1/2 billion last year... profits of over 90 million last year.. should bring a nice amount...

however the trend has not been good for TPL..

My guess 2 million anyone else care to speculate..?? so 5 or 10% will go directly to PTSC is my understanding... so we will need several more to get our 1.1 million back from The TPL settlement

http://finance.yahoo.com/q/is?s=CYMI+Income+Statement&annual

Dec 31, 2010Dec 31, 2009Dec 31, 2008
Period Ending
Total Revenue 534,209 307,664 459,010
Cost of Revenue 261,442 171,250 241,881
Gross Profit 272,767 136,414 217,129
Share
New Message
Please login to post a reply